1997
DOI: 10.1016/s0090-4295(96)00359-7
|Get access via publisher |Cite
|
Sign up to set email alerts

Primary gonadotropin releasing hormone and adjunctive human chorionic gonadotropin treatment in cryptorchidism: A clinical trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2001
2001
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 23 publications
0
4
0
Order By: Relevance
“…hCG therapy with or without combination of nasal spray of GnRH has been shown to be effective to treat cryptorchidism in neonates and prepubertal boys (304,305). This finding could represent a further benefit of neonatal treatment of children with CHH, as cryptorchidism is a factor of poor prognosis for adult fertility and is also a risk factor for testicular malignancy.…”
Section: Advance Article: Endocrine Reviewsmentioning
confidence: 89%
“…hCG therapy with or without combination of nasal spray of GnRH has been shown to be effective to treat cryptorchidism in neonates and prepubertal boys (304,305). This finding could represent a further benefit of neonatal treatment of children with CHH, as cryptorchidism is a factor of poor prognosis for adult fertility and is also a risk factor for testicular malignancy.…”
Section: Advance Article: Endocrine Reviewsmentioning
confidence: 89%
“…Hormonal treatment of cryptorchidism has been used to stimulate the secretion of testicular androgens and to override the imbalance leading to testicular retention [3, 11]. hCG and GnRH, alone or combined in various treatment schedules, are the main used hormones [2, 3, 4, 5, 6, 7, 8, 9, 12, 13, 14, 15], but their efficacy remains a debated issue [1, 2, 4]. In fact, great variation in testicular descent has been reported [2, 4], ranging from 0 to 90% [2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 13, 14, 15].…”
Section: Discussionmentioning
confidence: 99%
“…hCG and GnRH, alone or combined in various treatment schedules, are the main used hormones [2, 3, 4, 5, 6, 7, 8, 9, 12, 13, 14, 15], but their efficacy remains a debated issue [1, 2, 4]. In fact, great variation in testicular descent has been reported [2, 4], ranging from 0 to 90% [2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 13, 14, 15]. The inclusion of heterogeneous patient populations regarding the type of cryptorchidism (unilateral or bilateral), the site of testicular retention (abdominal or impalpable, inguinal, suprascrotal, high scrotal), and the age at hormonal treatment (from 1st year of life to adolescence) are considered causes of the different clinical results [1, 2, 3, 4, 13].…”
Section: Discussionmentioning
confidence: 99%
“…Patients with unilateral testicular absence should also be offered ment of UDT with both hCG and GnRH with encouraging results. 34 Studies support the use of GnRH in promoting the development of germ cells, as well as in promoting testicular descent. The results are variable, but the side effects are less than those seen with hCG.…”
Section: A N a G E M E N Tmentioning
confidence: 98%